Literature DB >> 23999972

Authors' reply to Rolland et al.: "Management of alcohol dependence in patients with liver disease".

Giovanni Addolorato1, Antonio Mirijello.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23999972     DOI： 10.1007/s40263-013-0108-4

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  8 in total

1.  Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers.

Authors:  Laurent Rigal; Constance Alexandre-Dubroeucq; Renaud de Beaurepaire; Claire Le Jeunne; Philippe Jaury
Journal:  Alcohol Alcohol       Date:  2012-03-19       Impact factor: 2.826

2.  EASL clinical practical guidelines: management of alcoholic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2012-05-26       Impact factor: 25.083

3.  Baclofen for alcoholism.

Authors:  James C Garbutt; Barbara Flannery
Journal:  Lancet       Date:  2007-12-08       Impact factor: 79.321

4.  Comment on: "Management of alcohol dependence in patients with liver disease".

Authors:  Benjamin Rolland; Sylvie Deheul; Alexandre Louvet; Olivier Cottencin; Régis Bordet
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

5.  Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician.

Authors:  Olivier Ameisen
Journal:  Alcohol Alcohol       Date:  2004-12-13       Impact factor: 2.826

6.  Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

Review 7.  Management of alcohol dependence in patients with liver disease.

Authors:  Giovanni Addolorato; Antonio Mirijello; Lorenzo Leggio; Anna Ferrulli; Raffaele Landolfi
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

8.  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.

Authors:  Giovanni Addolorato; Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Luisa Vonghia; Antonio Mirijello; Ludovico Abenavoli; Cristina D'Angelo; Fabio Caputo; Antonella Zambon; Paul S Haber; Giovanni Gasbarrini
Journal:  Lancet       Date:  2007-12-08       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.